Introducing ADI’s new CEO: Dr. Faith Mwangi-Powell
ADI announces our new CEO, joining on 1 October 2026
News, blogs and stories from across the field of dementia, the work of Alzheimer’s Disease International and our members.
ADI announces our new CEO, joining on 1 October 2026
In this guest article, ADI Board Member and dementia advocate, Bill Yeates, shares his post diagnosis journey, discussing the hopes and challenges of life between scans.
A new report by ADI calls on world governments to ensure that dementia remains a priority during and after the COVID-19 pandemic.
Catherine Hall, Chief Executive of Alzheimers New Zealand, writes about how Alzheimers New Zealand has responded and adapted to COVID-19, both in the first weeks of lockdown and today.
Alzheimer’s Disease International (ADI) and partner Dementia Alliance International (DAI) join other civil society organisations in a statement to the World Health Organization (WHO).
In advance of the 73rd World Health Assembly, ADI is sharing a statement submitted to the World Health Organization (WHO) and Member States.
A new study in the Lancet Neurology has shown that blood phosphorylated tau 181 may be a promising biomarker for Alzheimer’s disease.
ADI welcomes three new Alzheimer associations, as well as new members to the ADI board.
ADI releases a position paper on the difficult decisions people with dementia, their families and carers are having to make around hospital admission and triage during COVID-19.
Mario Possenti, CEO of ADI’s member Federazione Alzheimer Italia shares his gratitude to the Italian health workforce for their support of people living with dementia in the wake of the COVID-19 crisis.